Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug;9(8):435-44.
doi: 10.1038/nrgastro.2012.119. Epub 2012 Jun 26.

New biomarkers and targets in pancreatic cancer and their application to treatment

Eithne Costello  1 , William Greenhalf, John P Neoptolemos
Affiliations
Review

New biomarkers and targets in pancreatic cancer and their application to treatment

Eithne Costello et al. Nat Rev Gastroenterol Hepatol. 2012 Aug.

Abstract

Late diagnosis of pancreatic ductal adenocarcinoma (pancreatic cancer) and the limited response to current treatments results in an exceptionally poor prognosis. Advances in our understanding of the molecular events underpinning pancreatic cancer development and metastasis offer the hope of tangible benefits for patients. In-depth mutational analyses have shed light on the genetic abnormalities in pancreatic cancer, providing potential treatment targets. New biological studies in patients and in mouse models have advanced our knowledge of the timing of metastasis of pancreatic cancer, highlighting new directions for the way in which patients are treated. Furthermore, our increasing understanding of the molecular events in tumorigenesis is leading to the identification of biomarkers that enable us to predict response to treatment. A major drawback, however, is the general lack of an adequate systematic approach to advancing the use of biomarkers in cancer drug development, highlighted in a Cancer Biomarkers Collaborative consensus report. In this Review, we summarize the latest insights into the biology of pancreatic cancer, and their repercussions for treatment. We provide an overview of current treatments and, finally, we discuss novel therapeutic approaches, including the role of biomarkers in therapy for pancreatic cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Oncology. 2012;82(1):3-10 - PubMed
    1. J Natl Cancer Inst. 2003 Feb 5;95(3):214-21 - PubMed
    1. Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):445-53 - PubMed
    1. Nature. 2010 Oct 28;467(7319):1109-13 - PubMed
    1. Nat Rev Cancer. 2010 Apr;10(4):293-301 - PubMed

MeSH terms